Newsroom

Get in Touch

Krishna Knabe
Director of Communications

Alzheimer's Matters Blog

ADDF Impact

Meeting the Challenge of CTE

For CTE Awareness Day, we highlight our support of diagnostic tools and treatments for this disease. 

Top 5 Alzheimer's Advances in 2017

ADDF Impact

Top Five Alzheimer’s Advances in 2017

Our top five advances in 2017 spotlight the substantial progress we have made toward conquering Alzheimer’s and other neurodegenerative diseases.

Developing Drugs

Alzheimer’s Biomarkers, Explained

Learn what a biomarker is, why they matter to the ADDF, which biomarkers we have, and which ones we need.  

Resources

Featured Video

Developed by Dr. Roberta Diaz Brinton, allopregnanolone could become the first regenerative therapy for Alzheimer's. Support from the ADDF helped Dr. Brinton turn her idea into a therapy that is now in phase 2 clinical trials.

View more on our YouTube channel

Fact Sheets & Publications